Welcome to the UK-EGG Website
The UK Eye Genetics Group (UK-EGG) was set up in December 2002 for ophthalmic clinicians and clinical geneticists with a specialist interest and expertise in ophthalmic genetics, to keep up to date in the field of clinical ophthalmic genetics which is a rapidly evolving specialty. The aims of the group are to disseminate the following information:
- NHS initiatives in ophthalmic genetics and relevant funding
- Centers offering molecular genetic analysis
- Update of current research in ophthalmic genetics
- Provide a forum for interaction between clinicians and scientists
- Share research in applied fields
- Open discussion group
UK-EGG seeking to appoint a new Secretary
The UK Eye Genetics Group executive committee
is looking to appoint a new Secretary to the team
The UK Eye Genetics Group (UK-EGG) executive committee is looking to appoint a new Secretary to the team.
We are looking for a keen and motivated individual – an enthusiastic advocate of eye genetic research. As well as their individual responsibilities (see the attached role description), the postholder would be expected to help promote the role of UK-EGG to the wider eye genetics community and become integral members of the UK-EGG team, taking part in our regular committee meetings and discussions (4-5 teleconferences per year) chaired by the co-Presidents, Denize Atan and Mariya Moosajee.
The post is for one year initially, although the role could be extended for up to 2 years. We are looking for an early career research scientist or clinician in ophthalmology or genetics. This is a great national leadership opportunity.
There is no remuneration for the role (nor for any of the UK-EGG executive committee roles) except for registration and travel costs to the annual UK-EGG meeting.
Informal enquiries about the roles can be directed to the current Secretary, Gabrielle Wheway (email@example.com ) or co-presidents, Denize Atan (firstname.lastname@example.org) and Mariya Moosajee (email@example.com ).
Applications should be by submission of a 1/2 page statement covering briefly what the applicant will bring to the role and sent to Gabrielle Wheway (firstname.lastname@example.org ) before 18th August 2021. Note: if due to Summer Leave, potential candidates require additional time, please advise.
Shortlisted applicants will be invited to an informal Teams/ Zoom interview.
Description of job role
The UK-EGG Secretary is a key member of the UK-EGG executive committee. The postholder would be expected to help promote the role of UK-EGG to the wider eye genetics community and become an integral member of the UK-EGG team, taking part in regular committee meetings and discussions chaired by the co-Presidents, Denize Atan and Mariya Moosajee.
The main responsibilities are:
1. To process membership applications
2. To keep the membership database up-to-date
3. To respond to queries from members
4. To organise quarterly teleconference meetings
5. To organise the AGM at the annual UK-EGG meeting
6. To take minutes at meetings
7. To contribute to decision making as member of the executive
8. To provide administrative support for the annual meeting. Such support would include: applying for CPD points for the annual meeting from the Royal College of Ophthalmologists, printing and distributing attendance certificates, circulating feedback forms, aggregating and summarising feedback.
The Secretary role would suit someone relatively early career who has time to dedicate to this important administrative role and who is looking to widen their circle of connections within the eye genetics community. They would have input into shaping the future strategy and direction of the UK Eye Genetics Group. The ideal candidate must be organised, enjoy working as part of a team, and have a good understanding of the landscape of eye genetics both nationally and internationally.
The post is for one year initially, although the role could be extended for up to 2 years. There is no remuneration for the role (nor for any of the UK-EGG executive committee roles) except for registration and travel costs to the annual UK-EGG meeting.
UK-EGG Annual Meeting – Registration Store OPEN
Please join us on Tuesday, 21st September, 2021 at the Francis Crick Institute,
London for the UK Eye Genetics Group Annual Meeting
Early Bird pricing, saving £25, is available up to the 22nd August. UK-EGG Members also receive a further 20% on total.
To receive Members’ discount, please login using your membership username and password. If not a member, why not consider becoming one, you can purchase membership using the link below. If you have any queries email us at UKeyegenetics@gmail.com
UK-EGG Members receive an automatic 20% discount on Meeting Registration
Login using your membership username and password to access discount
To join UK-EGG use above Membership product button
UK-EGG Annual Meeting – Call for Abstracts
We would like to invite abstract submissions for:
- 7 min research talks plus 3 min Q&A for Early Career Researchers (ECR);
- 7 min interesting case presentations plus 3 min discussion with the audience;
- Research posters.
Prizes will be awarded for the best talk and poster.
For both talks and poster presentations please complete and submit the form below. Note you do not have to be a member of UK-EGG to submit an abstract.
If you have any queries, feel free to email us at UKeyegenetics@gmail.com
Abstract Submission closes 31st July, 2021
UK-EGG 2021 Annual Meeting - Abstract Submission Form
UK-EGG Annual Meeting – Registration COMING SOON
Please join us on Tuesday, 21st September, 2021 at the Francis Crick Institute,
London for the UK Eye Genetics Group Annual Meeting
We are excited to invite you to join us in sharing world-leading research from clinicians and researchers into ophthalmic genetics
The day will include sessions on “Advances in genetic eye disease”, “The future of genomic ophthalmology”, case presentations, as well as short research talks from Early Career Researchers and a research poster session.
Confirmed speakers include Professor Malindo Lako, Professor Stephan Beck, Professor Wendy Bickmore, Professor Andrew Webster and Dr Pearse Keane and a keynote presentation from Professor Tara Moore.
This meeting will be held both face-to-face and virtually, with all talks being live-streamed. Purchase your Registration above.
UK-EGG Webinar 4 - Registration NOW
Save the date for the UK-EGG Webinar 4: From bench to bedside: gene therapy to treat eye disease
We are pleased to announce the 4th UK-EGG Webinar: From Bench to Bedside: Gene Therapy to Treat Eye Disease will be held on Tuesday 6th of July 2021, from 5.30-7:00 pm. Please save the date!
We have 3 fantastic speakers lined up and there will be plenty of time for discussion and questions.
- Dr Erwin van Wijk
- Prof Robert MacLaren
- Mr Robert Henderson
Dr. Erwin van Wijk is an Assistant Professor at the Department of Otorhinolaryngology and the Donders Institute for Brain, Cognition and Behaviour (Radboud University Medical Center, Nijmegen, The Netherlands). He is head of the Usher Syndrome & Hereditary Hearing Loss Therapeutics Research Unit. His work to develop a genetic therapy for USH2A-associated retinal degeneration employing the zebrafish model has led to the use of antisense oligonucleotides (QR-421a) to modulate splicing of the frequently mutated exon13 of USH2A, for which the phase 1/2 clinical trial Stellar showed promising results. His research team works on the molecular mechanisms underlying Usher syndrome, non-syndromic inherited retinal dystrophies and inherited hearing impairment, and develops new treatment strategies for the many visually and hearing impaired individuals worldwide.
Mr Robert Henderson is a Consultant Paediatric Ophthalmologist and Adult & Paediatric Vitreoretinal surgeon at Great Ormond Street Hospital and Moorfields Eye Hospital. He is an Honorary Associate Professor at the UCL-GOSH Institute of Child Health. He has an expertise in both surgical and genetic paediatric retinal disease. He runs the inherited retinal dystrophy clinic at Great Ormond Street, and has pioneered a new dual sensory clinic for families with hearing and visual impairment. Mr Henderson leads the Voretigene ocular gene therapy programme, at Great Ormond Street, and is the UK Chief Investigator for the phase 4 post authorisation study.
His research programme is investigating the role of Wnt signalling pathways in retinovascular diseases, and he is starting a novel trial of intravitreal Cerliponase for the treatment of CLN2 related Battens Disease retinal dystrophy.
Members-Only areas coming SOON
Access to certain areas of the UK-EGG website are being made ‘Members-Only’, this includes recordings of Webinars and Meetings
Accounts for UK-EGG members have already been created. Over the next week, emails will be going out to all members, requesting that they reset their UK-EGG website password. When you receive this email, unless you have already used your account and know your password, either accept and note your password, or change it. Once this is done then please return to UK-EGG.com and login to your account. I suggest that the next thing that you do is explore the https://ukegg.com/webinar-recordings/ page and catch up on the excellent Webinars that have been held over the past months.
Geoff Cross – UK-EGG web site
A ‘Good Read’ – Tiny Happy People
Parenting with a visual impairment:
‘It’s all about building a connection, enabling them to grow and experiment’. Robin is visually impaired and dad to two sons, Tadhg, 5 and Arlo, 2 who are sighted.
Prof Mariya Moosajee @MariyaMoosajee… Really encouraging article on being a parent with sight loss. This couple had genetic counselling @Moorfields for family planning advice. As with all new parents you’re learning as you go & will find a way to adapt to give your child the most Red heart & care.
SAVE THE DATE –
UK-EGG Annual Meeting on Tuesday, 21st September, 2021
2021 Annual Meeting – Venue and Date for your Diary
Our annual conference was due to be held on Tuesday, 24th November, 2020, but due to concerns about ongoing social distancing and restrictions on large group meetings, we have taken the difficult decision to postpone our face to face meeting to Tuesday, 21st September, 2021. This will be held in the main auditorium of The Francis Crick Institute, London, with access to their gallery space, so there will be plenty of room to spread out and/or invite more guests.
UK-EGG Executive Committee: Mariya Moosajee, Denize Atan and Gabrielle Wheway
UK-EGG Webinar 3 – Countdown
Webinar 3 Countdown
UK-EGG Webinar 3 – Agenda
Rapid fire poster session
5:35pm: 3 minute posters followed by an open panel questions to speakers
- An illustrative case of bilateral ectopia lentis due to mutations of the ADAMTSL4 gene– Aditi Das, Great Ormond Street Hospital, London
- High myopia referrals to the Genetic Eye Clinic: Are we being short-sighted?- Melody Redman, Yorkshire Regional Genetics Service, Leeds.
- Exome Sequencing of mendelian genes in syndromic and non syndromic patients with Microphthalmia Anophthalmia Coloboma identifies potentially causal mutations in 45%- Irina Balikova, University Hospital Gasthisberg, Belgium
- EPHA2 segregates with bilateral microphthalmia and congenital cataracts in two unrelated families- Philippa Harding, UCL Institute of Ophthalmology, London
- A systematic review of genetic mutations and clinical features associated with Late-Onset Retinal Degeneration- Randa Li, University of Edinburgh, Edinburgh.
- Ocular features associated with DYRK1A variants- Cécile Méjécase, UCL Institute of Ophthalmology, London
- Translational readthrough of ciliopathy genes BBS2 and ALMS1 using patient fibroblasts- Jonathon Eintracht, UCL Institute of Ophthalmology, London
- Genome-wide study of retinal vascular complexity identifies 8 novel loci and unravels shared genetic with cardiovascular events– Ana Villaplana-Velasco, University of Edinburgh, Edinburgh.
- Metabolomic analysis of choroideremia patients plasma reveals systemic lipid metabolism dysfunction and oxidative stress– Dulce Lima Cunha, UCL Institute of Ophthalmology, London
6:10pm: A Qualitative study exploring the support requirements of families with inherited retinal dystrophies and how they obtain information- Manara Gul, University of Cardiff, Cardiff
6:22pm: Retrospective natural history study of a UK cohort of cerebrotendinous xanthomatosis– Suzannah Bell- Moorfields Eye Hospital, London
6:34pm: Characterisation of foveal development and cone photoreceptor specialisation in SLC38A8 mutations- Helen Kuht, The University of Leicester, Leicester
6:46pm: The role of BMP3 in the development of myopia- Amy Findlay, University of Edinburgh, Edinburgh.
UK-EGG Webinar 3 – Speakers
A Qualitative study exploring the support requirements of families with inherited retinal dystrophies and how they obtain information.
Supervisor: Roberta Rizzo
University of Cardiff
Retrospective natural history study of a UK cohort of cerebrotendinous xanthomatosis
Clinical research fellow/ ST1 Ophthalmology trainee
Mariya Moosajee Group
Moorfields Eye Hospital NHS Foundation Trust, London, UK
Characterisation of foveal development and cone photoreceptor specialisation in SLC38A8 mutations
Supervisor: Mervyn Thomas
The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester
The role of BMP3 in the development of myopia
Post-doctoral Research Scientist
Veronique Vitart Group
MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh
Helen graduated from the University of Sheffield in 2016 with first-class honours in Orthoptics and was subsequently appointed as a research orthoptist at the University of Leicester. Helen is currently undertaking a part-time PhD, providing insights into foveal developmental disorders using deep phenotyping techniques. She have a special interest in genotype-phenotype relationships associated with developmental disorders of the eye, and the application of artificial intelligence in paediatric ophthalmology.
Amy completed her PhD in the lab of Martin Collinson, University of Aberdeen, studying the role of planar cell polarity genes in the maintenance of corneal transparency. She then moved to MRC Human Genetics Unit, University of Edinburgh, to work in the labs of Ian Jackson and then Veronique Vitart. Here she has developed her interest and skills in using disease models to better understand the mechanisms of sight loss. She hopes to continue this work in future and believes that by investigating the molecular basis of eye disease we can better develop therapeutics in the future.
Register NOW for UK-EGG Webinar 3
All UK-EGG members are warmly invited to join the third in our series of webinars for the UK Eye Genetics community, aimed at enabling virtual contact between members at a time of great disruption as a result of COVID-19. Our third webinar will highlight the work of our early career members from all areas of UK Eye Genetics and will be held on Thursday, 15th April from 5.30pm to 7.00pm.
There will be a fantastic selection of posters and short talks selected from abstracts submitted by our early career members from different areas of UK Eye Genetics, including:
- Clinical Genetics
- Clinical Research
- Population Genetics
- Basic Research/Disease Mechanisms
- Genetic Counselling
Countdown to Webinar 3
UK Genetic Specialist Clinics
We have added a list of Genetic Specialist Clinics around the country to our Links Page
Late Onset Retinal Degeneration (L-ORD)
L-ORD Information Request
Ophthalmologists and researchers in Edinburgh led by Professor Bal Dhillon have an interest in Late Onset Retinal Degeneration (L-ORD), a rare autosomal dominant disease caused by mutations in C1QTNF5. We would like to build a better picture of the prevalence of L-ORD across the UK and to identify clinical colleagues who are involved in the diagnosis, management and care of L-ORD patients. We would be grateful if you would please contact Prof. Bal Dhillon or Chloe Stanton with details of the number of patients and the location in which you have worked with them.
More details about our work on L-ORD at the University of Edinburgh can be found via link from button below:
The UK Eye Genetics Group was set up in 2002 for ophthalmic clinicians and clinical geneticists with a specialist interest and expertise in ophthalmic genetics, to keep up to date in the field of clinical ophthalmic genetics which is a rapidly evolving specialty.
16 years of support for ophthalmic clinicians and clinical geneticists